Cancer therapeutics specialist ValiRx Plc (LON:VAL) said its standby equity distribution agreement with Yorkville (YA) is now done and dusted.
YA elected to convert all remaining US$520,000 of its convertible loan notes from the second tranche of its loan facility into 25.2mln ValiRx shares at a conversion price of 1.5429p a share.
No further amounts on Tranche 2 of the convertible loan notes (CLNs) remain outstanding. As previously announced Tranches 1 and 3 have been fully repaid and so this is the final conversion under the CLN facility.